This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Fresenius Kabi Oncology Limited. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Vikas Bhandari: Innovator in Pharmaceutical Compositions
Introduction
Vikas Bhandari is a notable inventor based in Gurgaon, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for compounds that are susceptible to hydrolysis. His work is essential for improving the efficacy and stability of pharmaceutical products.
Latest Patents
Vikas Bhandari holds a patent for a process titled "Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis." This invention outlines a method that includes the addition of pharmaceutically acceptable lyophilization excipients, the use of organic solvents, and specific temperature controls to create stable pharmaceutical formulations. The process aims to enhance the stability of compounds that are prone to hydrolysis, ensuring their effectiveness in medical applications.
Career Highlights
Vikas Bhandari is currently employed at Fresenius Kabi Oncology Limited, where he continues to innovate in the pharmaceutical sector. His expertise in creating stable formulations has positioned him as a valuable asset to his company and the industry at large.
Collaborations
Some of his coworkers include Dhiraj Khattar and Rajesh Khanna, who contribute to the collaborative environment at Fresenius Kabi Oncology Limited. Their teamwork fosters innovation and drives advancements in pharmaceutical research.
Conclusion
Vikas Bhandari's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving drug stability and efficacy. His work is vital for the ongoing development of effective pharmaceutical compositions.